Dextrans are a class of carbohydrate polymers extensively applied in pharmaceutical applications, particularly as drug conjugate macromolecular carriers or drug delivery systems. These polysaccharides enable the stability of the therapeutics to be improved and for them to be delivered in a controlled manner, via either the parenteral and oral routes. In the latter case, due to their gel forming ability they may have potential as hydrophilic matrix tablets for sustained drug release.
Introduction
Dextrans are a family of high-molecular-weight polymers composed of D-glucose units interconnected with α-1,6 linkages, with a variable degree of side branches via α-1,2, α-1,3, or α -1,4 linkages. In most cases the length of the side chains is short, and branched residues vary between 5-33 %. Commercial dextrans are about 95 % α-1,6 linked and 5 % α-1,3linked [1] .
Dextrans are biosynthesised from sucrose by several species of bacteria (e.g. Leuconostoc and Streptococcus), through the use of specific enzymes like glucansucrases [2] . Their physicochemical properties are mainly related to molecular weight (M w ) and degree of branching, which in turn depend on the source of production [3] .
In the last few decades dextrans have been mainly used as plasma volume expanders [2, 3] .
However recently, dextrans have shown the potential to be used in several drug and gene delivery systems [4] [5] [6] . Therapeutics have been formulated as polymer-drug conjugates or in the form of hydrogels or particulate drug delivery systems [3, [6] [7] [8] [9] [10] . Fülöp et al. [11] described the use of cyclodextrins (β type) grafted dextrans to solubilize hydrocortisone. Dextrans have been also evaluated for the preparation of targeting carrier systems particularly to deliver the drug into the colon [12] [13] [14] [15] . A further application of this class of polysaccharides is their use as oral tablet excipient. A commercial tablet formulation based on Limaprost (e.g. Opalmon ® ), an alprostadil (prostaglandin E1) analogue, employing dextran (40 kDa) and dextrin as excipients, has been marketed in Japan. A series of studies demonstrated how the presence of the carbohydrates could improve the stability of the Limaprost under high levels of humidity [16] [17] [18] .
Moreover, dextrans have been extensively utilized as controlled release polymer excipients in the preparation of oral hydrophilic matrix tablets [19] [20] [21] [22] [23] .
Korner et al. [23] , compared dextrans (M w 70, 500 and 2000 kDa) to polyethylene oxides (PEOs) and hydroxypropyl methylcelluloses (HMPCs), analyzing the release and swelling mechanisms in correlation with the intrinsic viscosity (which in this case is an indirect measure of molecular 4 weight) of the polymer. Gil and co-workers (2006, 2007 and 2008) showed the potential of medium molecular weight dextrans for immediate release, whilst the higher molecular weight (more than 2000 kDa) was more suitable in the formulation of extended drug release tablets.
Based on these promising results, it has been decided to integrate the knowledge concerning the use of dextrans as excipients in the formulation of matrix tablets, taking into account the mechanical properties of the powders and how they are affected by the production speed and storage conditions. Dextrans with different molecular weights (1, 40, 500 and 2300 kDa) were selected from within those approved for pharmaceutical use, with the only exception of that of the highest molecular weight, which is at this time only approved as a food ingredient.
All the dextrans were characterized in terms of their powder properties and tabletability. Moreover, their ability to act as controlled release agents was evaluated through dissolution studies, using hydroxypropyl methylcellulose (4000 cps), a common polymer used in controlled release systems, as reference material. The dissolution profiles, using tramadol as model drug, were explained in terms of the swelling ability of the formulated tablets. 5
Materials and methods

Materials
Dextrans with molecular weight of 1 kDa (Dextran 1 EP), 40 kDa (Dextran 40 EP) and 500 kDa (Dextran 500 pharmaceutical quality) were provided by Pharmacosmos A/S (Holbaek, DK), while a dextran of 2300 kDa was supplied by BIOerg srl (Jesi, IT). Hydroxypropyl methylcellulose 4000 cps (Methocel K4M) was provided by Colorcon (Dartford, UK). Microcrystalline cellulose (Avicel PH 101) was provided by FMC BioPolymers (Brussels, BE) and tramadol hydrochloride was generously donated by the company Janssen-Cilag SpA (Borgo San Michele, IT). All the others materials were reagents of standard grade and were supplied by Sigma-Aldrich (St. Louis, USA).
Throughout the text the material names will be reported with the following abbreviations: D_1kDa, D_40kDa, D_500kDa and D_2300kDa for dextrans with molecular weight of 1, 40, 500 and 2300 kDa, respectively and HPMC and MCC for hydroxypropyl methylcellulose 4000 and microcrystalline cellulose. Molecular weight of the D_1kDa, D_40kDa and D_500kDa were provided by the manufacturer, while for the D_2300kDa was determined using size exclusion chromatography coupled to multi-angle light scattering (SEC-MALS), as described in the supplementary material SMT_1.
Particle size analysis
All the dextran powders were analyzed using optical microscopy (MT9000 Polarizing Microscope, Meiji Techno Co Ltd, JP) equipped with a 3 megapixel CMOS camera (Invenio 3S, DeltaPix, DK).
The acquired images (2048 x 1536 pixels) were analyzed through the use of image analysis software (Image Pro Plus, MediaCybernetics Inc., USA), previously calibrated using a specific glass slide with a 5 mm graticule (S2-StageMic, Graticules Ltd, UK). One hundred particles, randomly selected, were analyzed in terms of projected area equivalent diameter. The obtained data 6 were analysed using the software Minitab 15 (Minitab Inc., State College, USA), in order to measure the most representative parameters of particles size distributions.
Density and flowability
The bulk (ρb) and tapped (ρt) densities of the samples were determined by pouring a pre-weighted amount of sample in a cylinder and measuring the volume occupied initially and after 300 taps respectively (after 200 taps the powder volume remained constant).
Carr's index was estimated from the bulk and tap densities according to equation 1. Bulk and tapped densities were determined in triplicate.
Hygroscopicity
Dextran hygroscopicities were determined by leaving the samples at ambient conditions and measuring water content at predetermined time intervals using a moisture analyzer (SMO 01,
Scaltec, DE)
When the stable moisture content was reached, the powders were placed in a desiccator containing calcium chloride and the water content was monitored as previously described in the tests at ambient conditions.
The temperature and the moisture percentage were monitored twice a day during both experiments, giving the following average conditions: (ii) 20.7 ± 1.1 °C and 6.1 ± 1.4 % during the experiments performed inside the dessicator.
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The tests were also performed on two control polysaccharides, MCC and HPMC. MCC was selected as example of a direct compression excipient while HPMC as controlling release excipient.
Tabletability
Dextran tablets were prepared using a fully instrumented 10 station rotary tablet press (Ronchi, IT).
Details of mounted traducers and their calibration have been previously reported [24, 25] . The Where D is the tablet diameter and t the tablet thickness, measured using a micrometer (103-137, Mitutoyo, Japan).
The analyses were repeated also for the samples left under ambient conditions for the appropriate times necessary to reach stable moisture contents. The hardness of each batch was determined by measuring 10 tablets.
Tablet stability
Dextran matrices were prepared by setting the punch penetration in order to produce 100 mg tablets 8
In this analysis, the hardness values were not transformed in tensile strength. During the monitored period, the tablets prepared with D_1kDa lost their regular shape making impossible the measurement of the diameter and thickness values necessary for the calculus of the tensile strength.
Dissolution testing
Five batches of tablets were prepared by compression of blends composed of 49.5 mg dextran (D_1kDa, D_40kDa, D_500kDa and D_2400kDa) or HPMC (used as control), 49.5 mg tramadol and 1 mg of magnesium stearate (lubricant). All tablets were characterized by the same hardness, equal to 30 N (effective values were 30.9 ± 2.5).
Dissolution studies were performed at 37 ± 0.5 °C using an USP dissolution apparatus 1 (AT7 smart, Sotax, CH) with rotation speed of 50 rpm. Potassium phosphate buffer (50 mM) pH 6.8 (700 ml) was selected as medium according to previously reported studies concerning tramadol release [26, 27] . For each batch 3 tablets were tested and drug release was monitored spectrophotometrically at 271 nm (UV-1800, Shimadzu Corporation, JP) for a period of 4 hours.
Tablet swelling
The analysis of tablet swelling was performed using the same procedure followed by Roberts at al.
(2007) to study HPMC matrix tablets [28] . Briefly, each tablet was placed vertically in a small glass Petri dish, and 10 ml of dissolution medium was added at ambient temperature. The Petri dish was placed on a plane surface and the digital camera was placed above. 
Results and discussion
Particle size and flowability analysis
Microscopic images of the different dextran powders are reported in Figure 1 . They appear to be characterised by differently shaped fine particles, with sizes lower than 50 µm. Specifically, all the samples provided by Pharmacosmos, D_1kDa, D_40kKDa and D_500kDa, showed a perfect circular shape with a darker inner core, while the sample D_2300kDa was made up by particles of irregular shape. The observation of particles with smaller size and perfectly round shape suggests that low molecular weight dextrans were probably produced by spray drying, this is supported by comparison of similar images reported in the previous literature [29] . On the other hand, the particles images of the sample with highest molecular weight suggest that it was probably obtained through a milling process.
All the images acquired were further processed using image analysis software in order to measure the size of each single particle and obtain the particle size distributions of the different batches.
These results are summarized in the Figure 2 using the box plots. Although the dextran samples were produced using different techniques, they show very similar results. The median particle size ranged from a value of 15.9 µm for the D_1kDa to 22.8 µm for D_2300kDa (table 1) , while the width of the distributions, calculated as the interquartile range, varied between 7.6 µm to 13.4 µm for the samples D_1kDa and D_500kDa, respectively (table 1). All the particle size distributions were slightly asymmetric, having the right tail longer than the left one (the values of skewness were in the interval 0.5 to 1.3 for all the samples). [30, 31] , comparable with the values found for dextran samples.
Hygroscopicity
The ability to take up water from the environment is a central attribute of any powdered material that strongly influences its storage and handling conditions. The water bound to the hydrophilic groups of a substance acts as a plasticizer and can markedly change its properties (e.g. tabletability, flowability and stability) [32, 33] .
All polymeric materials with a high number of hydrophilic groups along their backbone, whilst being glassy or possessing glassy regions (e.g. dextrans), are able to adsorb high amounts of water and consequently change their physical properties [32, 34] .
The kinetics of water absorption and desorption when the powders were stored at ambient and dry conditions are reported in Figure 3A and This sample becomes a "rubbery block" as it absorbs water. In this condition, the moisture analyser was not be able to accurately determinate the weight loss since the water is more strongly bound.
The change of the powder 1_kDa into a block makes it virtually useless for the preparation of solid 11 dosage forms. Thus for dextrans of lower molecular weight the storage and handling conditions have to be rigorously controlled.
Water absorption was revealed to be a reversible phenomenon, as is evident from Figure 3B . When the samples were stored at around 6 % environmental humidity, they slowly released the absorbed water (most of the samples returned back at the initial moisture values after 15 days). All the samples had a similar behaviour, with water desorption curves almost overlapping. The sample 1_kDa always remained as a "block". However, its consistency changed from rubbery to rigid and friable.
The control materials showed similar absorption kinetics than dextrans, even if the total amount of absorbed moisture was lower. Also in this case, the process appeared to be reversible when the samples was stored at dry conditions.
Tabletability and tablets stability.
Tabletability is one the most relevant features of excipients intended for the preparation of pharmaceutical solid dosage forms. It represents the ability of a material in powder form to produce tablets with good mechanical properties.
In this work, all the dextrans were characterized in terms of tabletability highlighting the effect of molecular weight, compaction speed and moisture absorbed. These results are summarized in In Figure 4A the curves of the samples with the initial moisture content (the values at time zero in Figure 3A ) are reported. Dextrans showed good tabletability, being able to produce tablets with tensile strength in the range 5-12 MPa when compressed at 200 MPa. Such results suggest that dextrans have a tabletability almost comparable with that of microcrystalline cellulose and much higher than many other pharmaceutical excipients used as diluents or controlled release polymers in the direct compression process [35, 36] . There is no apparent trend taking into account the molecular weights. Samples with a weight of 40 kDa and 500 kDa had the higher tabletability. It is interesting to observe that up to 100 MPa, all the samples have the same behaviour, with data almost overlapped, while it is only at higher pressure that polymers with different M w begin to show a variable tabletability. There is no effect of production speed, with the exception of the D_2300kDa. Such a difference is most probably due to the different moisture content (10 % versus 6-7 % for the others polymers), as previously discussed. Figure 4B presents the tabletability of the samples exposed at ambient conditions for 8 days (they have a moisture content as defined at the time point "8 days" in Figure 3A ). There is no data for the sample D_1kDa since it was no longer in a suitable state to be loaded into the rotary tableting instrument. At higher moisture content dextran powders were more tabletable, but only at the lower compaction pressure (50-100 MPa).
Moreover, also the production speed begins to affect the tablet behaviour. In fact, the tablets produced at the lower speed are slightly harder, even if only at the higher compaction pressure applied. These results are not unexpected; water acts as plasticizer increasing the material's viscoelasticity. This results in higher ductility (better tabletability) and also more strain rate sensitivity (higher tabletability at low production speed) [37] [38] [39] . These results show that dextran powders are characterized by a certain hygroscopicity, which affects their compaction behaviour.
The next step is to verify whether the environmental conditions have a similar effect on the mechanical properties of dextran tablets, which were produced with the polymer "as received" and then stored at ambient conditions. The test was only performed on the sample D_1kDa, since this material was more sensitive to the absorbed moisture and to the D_500kDa sample, which was used as a "typical" dextran as it had a comparable behaviour to that of all the other dextrans.
The amount of sorbed moisture, expressed as variation of tablet weight, and the tablet hardness are reported in Figure 5 . Tablets prepared with the two dextrans, D_1kDa and D_500kDa, showed 
Dissolution testing
To evaluate the ability of dextrans to work as controlled release excipients, matrices containing tramadol hydrochloride as model drug were prepared with the four different dextrans and with HPMC K4M as model controlled release polymer.
Dissolution profiles and dissolution rate traces are shown in Figures 6A and B, respectively.
Dextran controls the drug dissolution as a function of their molecular weight, with the 50 % of tramadol released at 3, 6.5, 9 and 42 minutes for the D_1kDa, D_40kDa, D_500kDa and D_2300kDa, respectively.
In any case, their ability to prolong drug dissolution was less effective than HPMC. The sample D_2300kDa provided an anomalous dissolution profile; the release of the drug was very slow and superimposable to that of HPMC matrices during the first 30 minutes and then accelerates to finish after 2 hours. This aspect is clearly visible analysing the dissolution rates (Figure 6B) . All the samples, including HPMC, have a maximum dissolution rate at 5 minutes and then the process slows down up to a rate of zero in a time dependent manner for each polymer type. The only exception is the sample D_2300kDa, which show 2 peaks in the dissolution rate profiles, one at 5 minutes and the other at 45 minutes.
Tablets swelling
To explain the results obtained during the dissolution studies, all the tablets were tested in terms of the variation of their axial and radial dimensions. Percent normalised size variation was calculated as the axial or radial length increase/decrease with respect to the initial value.
Results (Figure 7) showed marked differences in the swelling behaviour of the tablets as a function of dextran molecular weight both in the axial and radial direction. The main behaviour of the polymers moves from a completely erosive mechanism for the D_1kDa to an almost predominantly swelling mechanism for the D_2300kDa.
In the first case, the tablets dissolve in less than 20 minutes while in the latter there is a size increase of more than double with respect to the initial dimensions. The polymers with a molecular weight of Swelling results appear to be related with the thickening ability of the different dextrans, as reported in the supplementary materials SMT_2. Thus, a purely erosive behaviour is observed with the only polymer having a virtually zero thickening power while the degree of swelling is associated with a particular dextran's ability to build up viscosity.
It is interesting to note as there is correlation between the dissolution profiles and the swelling data of the D_2300kDa. This sample, showed an increase of the drug release in the time range 30 and 60 minutes, which correspond to the time interval where the sample completely lost its regular shape (30 minutes) and break into pieces (60 minutes) during the swelling analysis. A completely irregular swollen tablet has a surface area much higher and consequently the drug is quickly released.
These results also allow an easy comparison between dextrans and HPMC. Dextrans suddenly swell or erode ending up to dissolve completely or break into pieces in less than 1 hour, while HPMC shows a constant and regular swelling which takes place during the entire duration of test. This difference can be attributed to the different properties of the gelled layer around the tablets and consequently to the thickening ability of the polymers (SMT_2). As the thickening power of the polymers decrease, the gelled layer around the tablets will be less compact, allowing an easier water diffusion, faster polymers hydration and dissolution.
The data obtained analysing the axial swelling was qualitatively similar to those of the radial swelling. The only difference was in the absolute values of normalized size increase. In the axial parameters, for each time point the swelling was roughly the double respect to those measured in the radial direction. Such a result is consistent with the previously published paper on HPMC swelling [28, 40, 41 ].
Conclusions
Dextrans of molecular weights in the range of 1 kDa to 2300 kDa were tested in terms of their ability to produce tablets and to control tramadol release. All dextrans showed good tabletability, almost comparable with that of microcrystalline cellulose and much higher than many other pharmaceutical excipients. However, their use as controlled release polymer for the preparation of matrix tablets does not appear particularly promising. Dextran polymeric chains showed fast hydration kinetics with high amount of water absorbed, which turned into fast dissolution or fast swelling as a function of the molecular weight.
Nevertheless, these results suggest other uses for dextrans in tablet formulation both in pharmaceutical and nutraceutical products. Specifically, the sample with lowest molecular weight is a very promising candidate to be used as filler for immediate release tablets, thanks to its good tabletability and fast dissolution rate, while the sample with highest molecular weight could be an efficient disintegrant due to its swelling ability. 
Figures and table captions
SMT_2: Viscosity of the dextran and HPMC solutions
All the dextran solutions were prepared by dispersing the polymer in water under magnetic stirring, while the HPMC solutions were prepared through the "hot/cold" technique. Briefly, the HPMC powder was dispersed in 1/3 of the required amount of hot water (70°C) adding then the remaining amount of medium during the cooling phase at ambient temperature under magnetic stirring. All the solutions were left at 5°C for at least 24 hours before being analysed.
All the solutions were prepared in different range of concentrations (% w/w) in order to take into account their different thickening properties and consequently obtain comparable viscosity values (in the range of 0-1 Pa*sec).
Flow curves were determined with a controlled stress rheometer (Stress Tech, Reologica) by a steel cone-plate geometry (C40/4). Shear rate was increased from 1 to 150 sec -1 and the corresponding shear stress measured, at a constant temperature of 25 and 37°C.
Each sample was tested in triplicate.
The flow curves were then analysed to obtain the viscosity by the Power-law equation: n kγ σ  = Where σ is the shear stress, γ the shear rate, k the consistency index and n the power law index.
Power law equation is an easy rheological model able to describe the flow of Newtonian and many non-Newtonian systems. The consistency index k, also called power law viscosity, is related to the system viscosity while the power law index n is related to the flow patterns. n values equal to 1 indicate a Newtonian behaviour while values lower and higher than 1 suggest shear thinning and thickening behaviour respectively.
The results of power law analysis are reported in the following figure SMT_2. All the analysed polymers showed very different thickening ability and the following rank of viscosity (power law viscosity) values are observed: D2300_kDa >> D500_kDa > D40_kDa >>D1_kDa. It need to be highlighted that the sample D1_kDa had viscosity values comparable with that of pure water and consequently its thickening power is virtually nil, at least in the concentration range analysed (5-30%). The sample D2300 kDa showed definitely higher viscosity values among all the tested 34 dextrans, even if its thickening ability is not comparable with that of HPMC. In addition, all the samples are Newtonian except the HPMC and the D2300_kDa at the higher concentrations, where a pseudoplastic behaviour is observed.
No differences were observed at the two tested temperature, 25 and 37°C.
Figure SMT_2
: Effect of polymer type, polymer concentration and temperature on the power law viscosity (consistency index k) and the power law index (n) of aqueous dispersions.
